Atenolol improves ventricular function without changing plasma noradrenaline but decreasing plasma atrial natriuretic factor in chronic heart failure

Autonomic and Autacoid Pharmacology

Volumn 22, Issue 5-6, 2002, Pages 261-268

  Gabrielli, O ^a   Puyo A M ^c   De Rosa, A ^a   Armando, I ^b   Barontini, M ^b   Levin, G ^b  

^a HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

blockers; Atrial natriuretic factor; Catecholamines; Heart failure

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ATENOLOL; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE MARKER; DRUG EFFECT; DRUG MECHANISM; EXERCISE; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; NORADRENALIN UPTAKE; PATHOLOGY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REST; SIDE EFFECT; SYMPATHETIC TONE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIOMYOPATHY, DILATED; CATECHOLAMINES; CHRONIC DISEASE; ELECTROCARDIOGRAPHY, AMBULATORY; ERGOMETRY; EXERCISE; FEMALE; HEART; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; SYMPATHETIC NERVOUS SYSTEM; VENTRICULAR FUNCTION, LEFT;

EID: 0041622715     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2002.00266.x     Document Type: Article

References (47)

1. Australia-New Zealand Heart Failure Research Collaborative Group (1995). Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation, 92, 212-218.
2. BENEDICT, C.R., WEINER, D.H., JOHNSTONE, D.E. et al. For the SOLVD investigators (1993). Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the studies of left ventricular dysfunction (SOLVD) registry. J. Am. Coll. Cardiol., 22, 146-153.
3. BONOW, R.O. (1996). New insights into the cardiac natriuretic peptides. Circulation, 93, 1946-1950.
4. BRISTOW, M.R., GILBERT, E.M., ABRAHAM, W.Y. et al. For the MOCHA Investigators (1996). Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation, 94, 2807-2816.
5. CIBIS Investigators and Committees (1994). A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation, 90, 1765-1773.
6. CIBIS-II Investigators and Committees (1999). The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet, 353, 9-13.
7. COHN, J.N., LEVINE, T.B., OLIVARI, M.T., GARBERG, V., LURA, D., FRANCIS, G.S., SIMON, A.B. & RECTOR, T. (1984). Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med., 311, 819-823.
8. COLUCCI, W.S., PACKER, M., BRISTOW, M.R. et al. For the U.S. Carvedilol Heart Failure Study Group (1996). Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation, 94, 2800-2806.
9. EICHHORN, E.J., MCGHIE, A.L., BEDOTTO, J.B., CORBETT, J.R., MALLOY, C.R., HATFIELD, B.A., DEITCHMAN, D., WILLARD, J.E. & GRAYBURN, P.A. (1991). Effects of bucindolol on neurohormonal activation in congestive heart failure. Am. J. Cardiol., 67, 67-73.
10. EISENHOFER, G., GOLDSTEIN, D.S., STULL, R., KEISER, H.R., SUNDERLAND, T., MURPHY, D.L. & KOPIN, I.J. (1986). Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenyl-alanine in plasma, and their responses to inhibition of monoamine oxidase. Clin. Chem., 32, 2030-2033.
11. EISENHOFER, G., ESLER, M.D., MEREDITH, I.T., DART, A., CANNON, R.O. III, QUYYUMI, A.A., LAMBERT, G., CHIN, J., JENNINGS, G.L. &, GOLDSTEIN, D.S. (1992). Sympathetic nervous function in the human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine. Circulation, 85, 1775-1785.
12. FANCIS, G. (1994). Determinants of prognosis in congestive heart failure. J. Heart Lung Transplant., 13, 113-116.
13. FRANCIS, G.S., BENEDICT, C., JOHNSTONE, D.E., KIRLINE, P.C., NICKLAS, J., LIANG, C.S., KUBO, S.H., RUDIN-TORETSKY, E. & YUSUF, S. (1990). Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation, 82, 1724-1729.
14. FUJIMURA, M., YASUMURA, Y., ISHIDA, Y., NAKATANI, S., KAMAMURA, K., YAMAGGISHHI, M. & MIYATAKE, K. (2000). Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy. J. Card. Fail., 6, 3-10.
15. GESLIN, P., LE BOUIL, A., FURBER, A., DUPUIS, J.M., BOUHOURR, J.B., LANFRANCHI, J., MONASSIER, J.P., FERRIERES, M., TODEI, A. & ALLAIN, P. (1998). Plasma noradrenaline and the prognosis of chronic cardiac failure: a multicenter study. Arch. Mal. Coeur Vaiss., 91, 191-199.
16. GILBERT, E.M., ABRAHAM, W.T., OLSEN, S., HATTLER, B., WHITE, M., MEALY, P., LARRABEE, P. & BRISTOW, M.R. (1996). Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation, 94, 2817-2825.
17. GOLDSTEIN, D.S. (1995). Stress, catecholamines and cardiovascular disease. In: Clinical Assessment of Catecholaminergic Function, pp. 234-286. Oxford University Press, Inc., New York.
18. GOLDSTEIN, D.S., EISENHOFER, G., STULL, R., FOLIO, C., KEISER, H.R. & KOPIN, I.J. (1988). Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J. Clin. Invest., 81, 213-220.
19. HARA, Y., HAMADA, M., SHIGEMATSU, Y. et al. (2000). Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Jpn. Circ. J., 64, 365-369.
20. ISNARD, R., POUSSET, F., TROCHU, J.N., CHAFIROVSKA, O., CARAYON, A., GOLMARD, J.L., LECHAT, P., THOMAS, D., BOUHOUR, J.B. & KOMAJDA, M. (2000). Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am. J. Cardiol., 86, 417421.
21. IVERSEN, L.L. (1967). The Uptake and Storage of Noradrenaline in Sympathetic Nerves. Cambridge University Press, Cambridge.
22. MADSEN, B.K., KELLER, N., CHRISTIANSEN, E. & CHRISTENSEN, N.J. (1995). Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity. J. Card. Fail., 1, 207-216.
23. MAJID, P.A., NIZNICK, J., NISHZAKI, S., MORRIS, W.M. & SOLE, M.J. (1986). Favorable effects of pindolol in dilated cardiomyopathy. Chest, 90, 777-779.
24. MATTIOLI, A.V. & MATTIOLI, G. (1991). Modificazione neurormonali in pazienti con insufficienza cardiaca trattata cronicamente con betabloccanti. Cardiologia, 36, 549-556.
25. MERIT-HF Study Group (1999). Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet, 353, 2001-2007.
26. PACKER, M., BRISTOW, M., COHN, J.N., COLUCCI, W.S., FOWLER, M.B., GILBERT, E.M. & SHUSTERMAN, N. For the PRECISE Study Group (1996a). The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N. Engl. J. Med., 334, 1349-1355.
27. PACKER, M., COLUCCI, W.S., SACKNER-BERNSTEIN, J.D. et al. For the PRECISE Study Group (1996b). Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the Prospective Randomized Evaluation of Carvedilol in Symptoms and Exercise (PRECISE) trial. Circulation, 94, 2763-2769.
28. PFEFFER, M.A., BRAUNWALD, E., MOYÉ, L.A. et al. (1992). The effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement (SAVE) trial. N. Engl. J. Med., 327, 668-677.
29. RECTOR, T.S., OLIVARI, M.T., LEVINE, T.B., FRANCIS, G.S. & COHN, J.N. (1987). Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am. Heart J., 114, 148-152.
30. RICHARDS, A.M., DOUGHTY, R., NICHOLLS, M.G., MACMAHON, S., IKRAM, H., SHARPE, N., ESPINER, E.A., FRAMPTON, C. & YANDLE, T.G. For the Australia-New Zealand Heart Failure Group (1999). Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Circulation, 99, 786-792.
31. ROSE, C.P., BURGESS, J.H. & COUSINEAU, D. (1985). Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload. J. Clin. Invest., 76, 1740-1747.
32. ROULEAU, J.L., DE CHAMPLAIN, J., KLEIN, M. et al. (1993). Activation of neurohumoral systems in post infarction left ventricular dysfunction. J. Am. Coll. Cardiol., 22, 390-398.
33. SANDERSON, J.E., CHAN, W.W., HUNG, Y.T., CHAN, S.K., SHUM, LO., RAYMOND, K., & WOO, K.S. (1995) . Effect of low dose β-blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomized comparison of metoprolol and a third generation vasodilating β-blocker. Br. Heart J., 74, 502-507.
34. SARDA, I.R., DE BOLD, M.L. & DE BOLD, A.J. (1989). Optimization of atrial natriuretic factor radioimmunoassay. Clin. Biochem., 22, 11-15.
35. SPANN, J.F., CHIDSEY, C.A. & BRAUNWALD, E. (1964). Reduction of cardiac stores of norepinephrine in experimental heart failure. Science, 145, 1439-1441.
36. STANEK, B., FREY, B., HÜLSMANN, M. et al. (2001). Prognostic evaluation of neurohumoral plasma levels before and during β-blocker therapy in advanced left ventricular dysfunction. J. Am. CoIl. Cardiol., 38, 436-442.
37. STEVENSON, L.W. (2002). Beta-blockers for stable heart failure. N. Engl. J. Med., 346, 1346-1347.
38. 1-blockade with atenolol on progression of heart failure in patients pretreated with high-dose enalapril. Eur. J. Heart Fail., 2, 407-412.
39. SWEDBERG, K., HELD, P., KJERKSHUS, J., RASMUSSEN, K., RYDEN, L. & WEDEL, H. On Behalf of the CONSENSUS-II Study Group (1992). Effect of the early administration of enalapril on mortality in patients with acute myocardial infarction. in N. Engl. J. Med., 327, 678-684.
40. The CONSENSUS Trial Study Group (1987). Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (Consensus). N. Engl. J. Med., 316, 1429-1435.
41. The SOLVD Investigators (1991). Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med., 325, 293-302.
42. The SOLVD Investigators (1992). Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N. Engl. J. Med., 327, 685-691.
43. VOGEL, J.H.K., JACOBOWITZ, D. & CHIDSEY, C.A. (1969). Distribution of norepinephrine in the failing bovine heart. Circ. Res., 24, 71-84.
44. WAAGSTEIN, F., BRISTOW, M., SWEDBERG, K., CAMERINI, F., FOWLER, M., SILVER, M., GILBERT, E., JOHNSON, M., GOSS, F. & HJALMARSON, A. For the Metoprolol in Dilated Cardiomyopathy Trial Study Group (1993). Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet, 342, 1441-1446.
45. YOSHIMURA, M., YASUE, H., OKUMURA K., OGAWA, H., JOUGASAKI, M., MUKOYAMA, M., NAKAO, K. & IMURA, H. (1993). Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 87, 464-469.
46. YU, C.M., SANDERSON, J.E., SHUM, I.O., CHAM, S., YEUNG, L.Y., HUNG, Y.T., COCKRAM, C.S. & WOO, K.S. (1996). Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur. Heart J., 17, 1694-1702.
47. ZUGCK, C., HAUNSTETTER, A., KRÜGER, C., KELL, R., SCHELLBERG, D., KÜBLER, W., HAASS, M. (2002). Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J. Am. Coll. Cardiol., 39, 1615-1622.